Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-01

Clinical Trial Update: Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating rapid elimination of teriflunomide using colestipol hydrochloride in healthy volunteers; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colestipol hydrochloride (colestipol hydrochloride)
  • Teriflunomide (teriflunomide)

Snippet

Sponsor: Derrick Scott Robertson | Conditions: Teriflunomide Elimination, Healthy Volunteers | Phase 1 | Status: TERMINATED | Results posted: 2019-07-01